| # | % | |||||
|---|---|---|---|---|---|---|
| 101 | CIDARA THERAPEUTICS INC | 122,628 | 1,719,000 | 0.09% | ||
| 102 | TANDEM DIABETES CARE INC COM | 155,300 | 1,683,000 | 0.09% | ||
| 103 | INCONTACT INC | 150,000 | 1,481,000 | 0.08% | ||
| 104 | INFINITY PHARMACEUTICALS INC | 112,600 | 1,233,000 | 0.07% | ||
| 105 | FEI COMPANY | 14,800 | 1,227,000 | 0.07% | ||
| 106 | MEDIDATA SOLUTIONS INC | 18,900 | 1,027,000 | 0.06% | ||
| 107 | XOMA CORP DEL | 152,200 | 591,000 | 0.03% | ||
| 108 | RAPTOR PHARMACEUTICAL CORP | 16,000 | 253,000 | 0.01% | ||
| 109 | VERASTEM INC | 10,900 | 82,000 | 0.00% | ||
| 110 | Codexis Inc Com | 10,000 | 39,000 | 0.00% |
Portfolio data is normalized using SEC Form 13F filings, including the Original 13F-HR (0001442891-15-000006, filed 2015.08.14).
From 2023-01-03 onward, the SEC requires values to be reported in nearest dollars. Earlier filings reported values in thousands; therefore, positions shown as $0 in older filings may represent actual values between $0–$999.
